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S U M M A R Y
Objectives: We compared the epidemiological, clinical and laboratory characteristics of enterovirus 71
(EV71) cases recorded in the epidemic year of 2008 with those of the past decade.
Methods: We estimated the annual incidence rates in the general population and in different age groups.
We reviewed the clinical and epidemiological information of the cases. The complication and case
fatality rates (CFR) were compared with the corresponding average rates for the period 1998–2007. The
molecular strains of EV71 isolates were determined.
Results: The estimated annual incidence was 1.4/100 000 in the general population, with the highest
incidence (27.9/100 000) reported among children aged under 5 years. The seasonal peak occurred from
May to July. The majority (92.9%) presented with hand-foot-mouth disease (HFMD; 90.8%) or
herpangina, and 11.2% had complications includingmeningitis or encephalitis (6.1%), pneumonia (3.1%),
acute ﬂaccid paralysis (1.0%), and shock (1.0%). The CFR was 1.0%. Nearly half (45.9%) of school-aged
cases had concurrent HFMD outbreaks at their schools/institutions. There was no statistically signiﬁcant
difference in the complications rate and CFR when compared to those of the past decade. Molecular
analysis showed that the majority were genogroup C4 strains, similar to the past circulating strains.
Conclusions: The cyclical high activity has had signiﬁcant public health and social implications. To
strengthen public health surveillance and control, EV71 infectionwasmade a statutory notiﬁable disease
in 2009.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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In the past few decades, infection with enterovirus 71 (EV71)
has become an emerging infection, especially in areas of Southeast
Asia. Although most patients present with a mild illness, such as
hand, foot, and mouth disease (HFMD) or herpangina, a small
proportion of patients may suffer severe complications such as
aseptic meningitis, encephalitis, acute ﬂaccid paralysis, myocardi-
tis, and even death.1–5 Young children are more susceptible and
this is the reasonwhy EV71 infection has capturedmuch attention.
A seroepidemiology study conducted in Singapore suggested that
the age-speciﬁc seroprevalence rate reached a steady state at
approximately 50% among children >5 years old.6 Outbreaks
occurring among these school-aged children have caused signiﬁ-
cant social disturbance to both children and their families. In Hong
Kong and Singapore, some schools having outbreaks of HFMD
associated with EV71 infection have required temporary class
suspension or even school closure in order to stop transmission of
the disease.7,8* Corresponding author. Tel.: +852 2125 2240; fax: +852 2711 0927.
E-mail address: smo_ss4@dh.gov.hk (E. Ma).
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1970 s, in Bulgaria, Hungary and Sweden, resulting in aseptic
meningitis, brain stem encephalitis and signiﬁcant numbers of
deaths.9–11 Over the period 1997–2000, the epidemic wave spread
to Southeast Asia affecting Malaysia, Taiwan, Singapore, and
Japan.1,12–14 The largest HFMD outbreak occurred in Taiwan in
1998 when over 100 000 cases of HFMD were reported; however
this was less than 10% of the estimated true ﬁgure.1 That outbreak
resulted in 400 patients with severe illness and 78 deaths. EV71
was a particular concern since the virus was isolated from 92% of
those who died.
An epidemic of EV71 infection was again detected in 2008,
involvingmany areas of Southeast Asia including Hong Kong.7,15,16
We assessed the public health implications in Hong Kong by
reviewing the epidemiological, clinical and laboratory character-
istics of EV71 cases, comparing them to those of the past decade.
2. Methods
In Hong Kong, EV71 has mainly been diagnosed by the Public
Health Laboratory (PHL) of the Department of Health (DH). Doctors
have also been requested to report EV71 infections to the DH on a
voluntary basis. All cases diagnosed by the PHL are investigated.
We identiﬁed cases from the PHL reporting system for the periodses. Published by Elsevier Ltd. All rights reserved.
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Figure 1. Number of enterovirus 71 cases reported to the Department of Health by year, 1998–2008.
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clinical presentation and isolation of EV71 or detection of EV71 by
polymerase chain reaction (PCR) from a clinical specimen. Upon
reporting of the EV71 cases, the patients or next of kin would be
interviewed by trained public health doctors or nurses for
epidemiological investigation and control purposes, including
contact tracing of home or other close contacts and controlling any
associated HFMD outbreaks in the child care institutions. Clinical
information including the onset date, clinical symptoms and signs,
complications, and outcome were obtained from the attending
physician or hospital record. These data were retrieved through an
electronic database that was reconstructed as the Public Health
Information System in 2002.
We estimated the annual incidence rates in the general
population and different age groups. The incidence was calculated
by the number of EV71 cases reported in 2008 divided by
population data obtained from the Census and Statistics Depart-
ment.17 The age-speciﬁc incidence was estimated similarly using
the populations of the different age groups. Themonthly number of
reported EV71 cases was calculated to determine seasonality.
The complication and case fatality rates (CFR) were calculated
by dividing the number of cases who had complications and the
number of fatal cases, respectively, by the total number of cases
reported. These rates calculated from cases reported in 2008 were
compared with the corresponding rates calculated from cases
reported for the period 1998–2007, in order to assess whether the
virus was more virulent and associated with more severe clinical
presentations and outcomes. We also compared the percentage of
cases requiring hospitalization, the median duration of hospital
care, and the likelihood of an association with an HMFD outbreak
at an institution. These rates were compared using the Chi-square
test with Yate’s correction whenever appropriate. The Mann–
Whitney U-test was used for statistical calculations to compare
duration of hospital stay, which was left-skewed.
Diagnosis was laboratory conﬁrmed, either by isolation of EV71
or detection of EV71 by PCR from a clinical specimen. Virus
isolation was performed according to conventional methods and
[(Figure_2)TD$FIG]Figure 2. Age-speciﬁc incidence of enterovirus 71 cases in 2008.the EV71 genome was detected by an in-house real-time reverse-
transcriptase PCR (RT-PCR). A phylogenetic tree was constructed
using the neighbor-joining method. The molecular epidemiology
of EV71 detected in 2008 was compared with that of previous
years.
3. Results
Ninety-eight EV71 cases were reported in 2008, the highest
annual ﬁgure in the last decade (Figure 1). The estimated annual
incidence was 1.4/100 000 in the general population, with the
highest incidence reported in children aged 0–4 years (27.9/100
000) (Figure 2). The seasonal peak was detected in May through
July, contributing to 65.3% of the cases, while a small winter peak
(October to December) was also noted, which was not seen in the
previous 10 years (Figure 3).
More males were affected than females, with a male-to-female
ratio of 1.1:1. The age of the patients ranged from 5 months to 42
years with a median age of 3.5 years. Seventy-one cases (72.4%)
were aged 5 years or less (Table 1). It was noticed that EV71 also
affected four adults (aged from24 to 42 years), accounting for 4.1%.
Among these four adult patients, three were family members of
pediatric cases and theywere identiﬁed during contact tracing. The
remaining adult patient also had a history of contact with a child
with HFMD, although no laboratory diagnosis was made for that
child.
The majority (90.8%) of cases presented with hand-foot-mouth
disease, while two cases suffered from the milder course of
herpangina. Others presented with non-speciﬁc symptoms includ-
ing fever, upper respiratory illness, non-speciﬁc skin rash, and
pneumonia. Sixty-one cases (62.2%) required hospital care with a
median duration of stay of 4 days. The majority of the cases
recovered uneventfully, while 11.2% of the cases suffered
complications including meningitis or encephalitis (6.1%), pneu-
monia (3.1%), acute ﬂaccid paralysis (1.0%), and shock (1.0%). There
was only one fatal case and the CFRwas 1.0%. An 11-month-old boyFigure 3. Number of enterovirus 71 cases reported to the Department of Health by
month, 1998–2008.
Table 1
Characteristics of enterovirus 71 cases in 2008, compared with cases reported from 1998 to 2007
2008 1998–2007 p-Value
No. of cases 98 195 –
Age distributiona
12 years old (%) 88 (89.8%) 183 (94.3%) 0.21
5 years old (%) 71 (72.4%) 156 (80.4%) 0.14
Male to female ratioa 1.1:1 (52:46) 1.6:1 (118:76) 0.20
No. of cases with travel history outside
Hong Kong during incubation period (%)
39 (39.8%): Mainland (38), Taiwan (1) 20 (10.3%): Mainland (19), Macao (1) 0.00
Clinical presentation 0.28
HFMD 89 185
Herpangina 2 4
Otherb 7 6
No. of cases requiring hospital care (%) 61 (62.2%) 98 (50.3%) 0.07
Duration of hospital care in days, median (range)c 4 (1–42) 4 (1–28) 0.80
No. of cases with complications 11 (11.2%): meningitis/encephalitis (6),
acute ﬂaccid paralysis (1), pneumonia (3),
shock (1)
12 (6.2%): meningitis/encephalitis (10),
acute cerebellar ataxia (1), pneumonia (1)
0.13
No. of deaths (case fatality rate) 1 (1.0%) 2 (1.0%) 1.00
No. of cases associated with an HFMD
outbreak in school (% among school age cases)
28 (28.6%) 83 (42.6%) 0.02
HFMD, hand, foot, and mouth disease.
a Age and sex information was missing for one case in the 1998–2007 group.
b Includes fever, upper respiratory infection, rash, and pneumonia.
c Information was missing for four cases in the 1998–2007 group and these patients were excluded from the analysis.
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shortness of breath in August 2008; his clinical condition
deteriorated rapidly and he was certiﬁed dead at the emergency
department despite resuscitation attempts. The cause of deathwas
attributed to interstitial pneumonitis, and a throat swab, tracheal
aspirate and rectal swab were all positive for EV71 by RT-PCR. His
three-year-old elder sister was also diagnosed to have EV71
infection, but she recovered without any complications.
Among the 61 cases whowere known to attend schools or child
care institutions, 28 (45.9%) of them had concurrent HFMD
outbreaks at their schools or institutions. These 21 HFMD
outbreaks affected a range of 2 to 25 persons. Most outbreaks
could be controlled with stepped-up infection control measures,
including the observation of strict personal hygiene practices by
frequent hand washing, thorough cleansing and disinfection of the
contaminated surfaces and soiled items, and excluding children
with HFMD from schools until fever had subsided and all the
vesicular lesions had dried and crusted. However, there was
evidence of sustained transmission of EV71 in six schools despite
implementation of these stepped-up measures. They required
temporary class suspension for 14 days in order to halt the
transmission of disease.
There were no statistical differences in the complication rate or
CFR when compared with the corresponding rates for the past 10
years (p-value = 0.12 and 1.00, respectively). There was no
statistical difference in the percentage requiring hospital care or
in the duration of stay in hospital in EV71 cases reported in 2008
compared to those reported in the past 10 years. Regarding the
proportion of associated HFMD outbreaks, the cases reported in
2008 were apparently less likely to be associated with an HFMD
outbreak when compared with the relevant ﬁgures of the past
decade. It was noted that a signiﬁcantly higher proportion of cases
in 2008 reported a travel history outside Hong Kong (mainly to
Mainland China) during the incubation period. However, it was
difﬁcult to ascertain the exact source of infection for these cases as
EV71 infection is endemic in both Hong Kong and the other areas
that the cases had visited.
Figure 4 illustrates the results of phylogenetic analysis for
1998–2008. It was found that the majority of the cases reported in
2008were C4 strains, whichwere also the predominant circulating
strains in the past 10 years. C1, C2, B3 and B4 strains were detected
in previous years, but only constituted a small proportion. In 2008,the rectal swab of a tourist from Taiwan was positive for EV71 by
PCR, and gene sequencing results showed it was a B5 strain. The
fatal case reported in 2008 belonged to C4, while the other two
fatal cases were C4 (reported in 2000) and B3 (reported in 1999).
4. Discussion
Our estimated incidence of EV71 infection in Hong Kong for
2008 was 1.4/100 000 in the general population, with the highest
incidence reported in children aged 0–4 years (27.9/100 000). The
true incidence was probably much higher because many patients
could have presented with only mild HFMD and been managed in
the out-patient setting and not tested. The bias due to under-
reporting by doctors was considered to be minimal, since not all
laboratories in Hong Kong have the capacity to isolate the EV71
virus or detect EV71 by PCR. In fact, the PHL of the DH is the
reference laboratory, which receives referral specimens from
public hospitals and private practitioners. Essentially, all EV71
cases were diagnosed by the PHL and the current review has
captured all laboratory conﬁrmed cases.
Apart from the usual EV71 peak season detected in the summer
months, we also noticed that therewas an increase in EV71 activity
in the winter months of 2008 (from October to December). This is
consistent with the ﬁndings of other surveillance systems for
HFMD reported in Hong Kong since 2006, including the number of
institutional HFMD outbreaks reported to the DH, the sentinel
surveillance systems based at general practitioners and child care
centres.18 EV71 contributed to a higher proportion of circulating
enteroviruses throughout the whole year of 2008 compared to
2006 and 2007, although according to the laboratory surveillance
in these 3 years coxsackie A viruses were still predominant. It is
interesting to note that such a bimodal peak for HFMD has also
been observed in other Asian countries including Singapore but not
in Taiwan in recent years.19,20
It is often a worry that a high circulation of EV71 will result in
worse clinical presentations and outcomes. In the epidemic of
HFMD in Taiwan in 1998, EV71 was isolated in 78 patients with
various complications and in 34 of the fatal cases.1 Our analysis
showed that both the complications rate and the CFR were not
statistically signiﬁcant when compared to the data of past years.
The complication rate in 2008 was 11.2%, slightly higher than the
average of 6.2% during the period 1998–2007. A similar higher
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Figure 4. Phylogenetic analysis of enterovirus 71 cases in Hong Kong, 1998–2008.
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vs. 50.3% in 1998–2007). This might be partly attributed to the
enhanced hospital-based surveillance system for HFMD imple-
mented in early May 2008 in Hong Kong in view of the HFMDoutbreak occurring in Mainland China.15 To facilitate early
detection of severe infections of HFMD and implement public
health actions, from May 2008 doctors in Hong Kong were
requested to report clinical cases of HFMD with severe complica-
E. Ma et al. / International Journal of Infectious Diseases 14 (2010) e775–e780 e779tions admitted to hospitals, even without laboratory conﬁrmation.
Among the 98 cases reported in 2008, ﬁve were reported through
this system and were subsequently conﬁrmed to be EV71
infections.
In 2008, the majority (63.6%) of cases with clinical complica-
tions occurred in children aged 5 years or younger. Meningitis and
encephalitis were the most commonly reported complications.
One patient suffered from acute ﬂaccid paralysis, which was also
seen in the outbreak in Perth, Australia in 1999 and in the Taiwan
outbreak in 1998.1,21 In contrast to the previous two reported fatal
cases in Hong Kong, the fatal case reported in 2008 did not have
any documented evidence of central nervous system complica-
tions. In the ﬁrst fatal case reported in 1999, a 2-year-old boy
suffered from brainstem encephalomyelitis with rapid cardiovas-
cular decompensation.22 The second fatal case reported in 2000
resembled the death cases experienced in Taiwan in the 1998
outbreak; a 5-year-old girl presented with meningoencephalitis,
complicated by pulmonary edema and pulmonary hemorrhage.
The cause of death in the 2008 case was interstitial pneumonitis.
Pulmonary complications due to EV71, although rare, are also
reported in the literature.23 After reviewing the 78 cases with
severe infections caused by EV71 in Taiwan, Ho et al. found that
there were nine cases with pulmonary edema or hemorrhage
without any neurological complications.1
Our epidemiological data suggest that there was a 3- to 4-year
cycle of high activity of EV71 infection in Hong Kong. Similar
surveillance ﬁndings have been reported inMalaysia, Taiwan, and
Japan.24–26 In fact, it has been suggested that there have been
three separate waves of EV71 activity worldwide, one in each
decade between1970 and2000,with the lastwave occurring from
1997 to 2000.27 Interestingly, about 10 years after the last wave,
an epidemic of EV71 again occurred in 2008, with many areas of
Asia, including Malaysia, Singapore, Taiwan and Mainland China,
reporting high activity of the disease. There are different
postulations for why the epidemics occur cyclically. The
emergence of new circulating strains has often been a focus.28
However, our ﬁndings do not suggest that there has been a major
change in the molecular epidemiology of EV71 in Hong Kong. In
2008, C4 was still the predominant circulating strain in Hong
Kong. Another postulation for the high cyclical activity is the
accumulation of a susceptible population. Lu et al. showed that
before the large epidemic in Taiwan in 1998, 40% to some 60% of
the study population was seropositive for EV71 in the period
1989–1993.29 However, in 1994 and 1997, a notably drop in
seroprevalence (20% to some 30%) of EV71 infection was detected
in the community. Such a buildup of a non-immune population
may facilitate a more efﬁcient transmission of the virus in the
community.
Although the clinical presentation and predominant strain of
EV71 in Hong Kong in 2008 were similar to those in past years, the
cyclical high activity has had signiﬁcant public health and social
implications. Currently there is no effective chemoprophylaxis or
vaccine for EV71. While we are waiting for an effective vaccine to
be developed, early case detection and prevention of secondary
spread appear to be the most effective public health measures for
controlling EV71 infection.30 To strengthen public health surveil-
lance and control, EV71 infection has been a statutory notiﬁable
disease in Hong Kong since March 2009.
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